Skip to content
This project aimed to monitor the prevalence of pneumococci bacteria not covered by the Prevenar vaccine. The Prevenar vaccine is currently administered to Indigenous Australian children and protects from disease caused by 7 types of pneumococcus, but studies showed that the remaining types of pneumococcus not included in the vaccine may become more prevalent.
In particular, the project examined the non-encapsulated pneumococcus which is an important replacement type in Indigenous children who have been vaccinated with Prevenar. Previously little was understood about the epidemiology of the is type of pneumococcus. This study assisted in the understanding of its relationship to other pneumococci, and its potential role as a reservoir of antibiotic resistance for pneumococci.
Abstract adapted from Menzies School of Health Research
Menzies School of Health Research
John Matthews Building
Royal Darwin Hospital Campus
PO Box 41096
Casuarina NT 0811
Ph: (08) 8922 8196
Fax: (08) 8927 5187